Streetbeat News

STVN

Stevanato Group S.p.A.

https://www.stevanatogroup.com

Industry

Medical - Instruments & Supplies

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Open

23.03

Mkt cap

6.4B

Volume

816K

High

24.90

P/E Ratio

51.80

52-wk high

34.73

Low

22.77

Div yield

0.00

52-wk low

16.56

Stevanato's Q3 2024 sales exceeded estimates, but adj. EBITDA and EPS fell short due to under-utilization and higher costs in the Engineering division. Despite these challenges, sequential margin improvement is expected, and long-term growth remains strong. The buy rating is maintained.

Portfolio Pulse from

November 13, 2024 | 6:30 am

Stevanato Group S.p.A. (NYSE: STVN) will participate in three upcoming investor conferences, including a fireside chat at the UBS Global Healthcare Conference on November 12, 2024.

Portfolio Pulse from

November 11, 2024 | 11:45 am

Stevanato Group S.p.A. (NYSE:STVN) held its Q3 2024 earnings conference call on November 5, 2024. Key participants included company executives and analysts from various financial institutions.

Portfolio Pulse from

November 05, 2024 | 7:30 pm

Stevanato Group is expanding its Vertiva platform to include a 10mL option, which will be presented at CPHI Milan in October.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:34 am

SCHOTT Pharma, Gerresheimer, and Stevanato Group have formed an alliance to promote Ready-to-Use (RTU) vials and cartridges, aiming to enhance efficiency and reduce risks in pharmaceutical packaging. The alliance seeks to lower operational costs and improve product quality, while also creating an open platform for industry standards.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:41 am

Several mid-cap stocks, including Semtech, Ambarella, and Box, saw significant gains last week due to positive financial results and analyst upgrades. These stocks experienced price target increases and insider share purchases, contributing to their strong performance.

Portfolio Pulse from Lekha Gupta

September 02, 2024 | 2:55 pm

Build-A-Bear Workshop and several other major stocks saw significant gains on Thursday, driven by strong earnings reports and positive guidance. The Dow Jones index also rose by around 400 points.

Portfolio Pulse from Avi Kapoor

August 29, 2024 | 5:06 pm

Citigroup analyst Patrick Donnelly maintains a Buy rating on Stevanato Group (NYSE:STVN) but lowers the price target from $30 to $28.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 7:26 pm

Stevanato Group shares are trading higher after the company reported better-than-expected Q2 revenue results.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 3:52 pm

Stevanato Group has provided its financial guidance for FY24, expecting adjusted EPS to be between €0.48 and €0.50, and revenue to range from €1.090 billion to €1.110 billion.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:20 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.